Skip to main content
Fig. 2 | BMC Veterinary Research

Fig. 2

From: Preliminary study on the effects of enrofloxacin, flunixin meglumine and pegbovigrastim on Mycoplasma bovis pneumonia

Fig. 2

Anti-M. bovis specific antibodies in the sera of the experimental and control calves post the treatment. NC, negative control; PC, positive control; E1, group received enrofloxacin alone; E2, group received enrofloxacin combined with flunixin meglumine; E3, group received enrofloxacin combined with flunixin meglumine and pegbovigrastim; 1, 2, 3 Id – the 1st, 2nd and 3rd infecting dose of M. bovis; Th – day of therapy starting; b, P < 0.05 between groups E1 and NC; c, P < 0.05 between groups E2 and NC; e, P < 0.05 between groups E1 and PC; f, P < 0.05 between groups E2 and PC

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us